HOME >> BIOLOGY >> NEWS
Clues to gene expression in cystic fibrosis will guide research

Genetics tests could help provide cystic fibrosis (CF) patients with targeted treatment in future, pilot study authors suggest. Results from a French clinical trial published today in BMC Medicine show how a small percentage of CF sufferers with a rare genetic stop mutation responded positively to gentamicin treatment.

Aleksander Edelman and Isabelle Sermet-Gaudelus of Facult de Mdicine Necker in Paris led collaborators from several French institutions studying how the antibiotic gentamicin affected CF patients with a stop mutation. The team used a dual reporter gene assay first in vitro and then in CF patients. The study found that a small subgroup of patients with the Y122X mutation, found mainly in inhabitants of Reunion island, responded to gentamicin treatment.

Cystic fibrosis is caused by mutations in the gene that encodes the Cystic Fibrosis Transmemrane Conductance Regulator (CFTR) protein. Over 1500 mutations have been described since this genes discovery. Premature stop mutations, which includeY122X, are found in around 10% of CF patients. Gentamicin reversed stop codons in the Y122X gene, and helped restore the CFTR protein, improving patients respiration.

Gentamicin itself may not be an ideal drug option, as it may cause serious side effects for some patients, including ear and kidney damage. The authors suggest that other drugs, such as amikacin or PTC124, with a comparable mode of action and fewer side effects, may have treatment potential. The in vitro method used to predict the trials outcome could be a first step to developing treatments effective for patients with CF and other diseases where premature stop codons play a role.


'"/>

Contact: Martyn Thomas
press@biomedcentral.com
44-020-763-19986
BioMed Central
28-Mar-2007


Page: 1

Related biology news :

1. Clues to future evolution of HIV come from African green monkeys
2. Unraveling Alzheimers: Clues may be found visualizing plaques in human brain, mad cowtype diseases
3. Clues to breast cancer hidden inside stem cells
4. Clues on cancer from a zebrafish model of melanoma
5. Clues to the puzzle of talking root cells
6. Clues to improving TB treatment
7. A low expression of MX2 gene exists in the white blood cells of narcoleptics
8. Gene expression pattern could lead to improved treatment of pediatric septic shock
9. Boston Univeristy bioengineers devise dimmer swith to regulate gene expression in mammal cells
10. Clocking in and out of gene expression
11. High cholesterol diets modify gene expression in atherosclerosis

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Clues gene expression cystic fibrosis will guide research

(Date:4/15/2014)... The Royal Netherlands Academy of Arts and Sciences (KNAW) ... who have been awarded prestigious Heineken Prizes (one million ... the Heineken Prizes for their great merits to science. ... first Heineken Prize, awarded to the Austrian-American chemist Erwin ... this year,s Heineken Prizes to the following laureates: ...
(Date:4/15/2014)... that the genetic code is far more complex ... building blocks adenine, cytosine, guanine, and thymine, numerous ... assume that the newly discovered nucleic acid modifications ... extends and complements the genetic code. "The new ... standard alphabet," explained Professor Mark Helm of the ...
(Date:4/15/2014)... April 15, 2014 New research, partially funded by ... Federation, shows that consumers can improve their diets simply ... their daily meals. , In a ... and Nutrition Sciences , lead author Theresa Nicklas, DrPH, ... and Nutrition Examination Survey datasets from 2005-2010 and evaluated ...
Breaking Biology News(10 mins):Five scientists awarded prestigious Heineken Prizes 2German Research Foundation approves new priority program in the life sciences 2Eating rice boosts diet quality, reduces body weight and improves markers for health 2Eating rice boosts diet quality, reduces body weight and improves markers for health 3
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
Cached News: